ZK 156718, a Low Calcemic, Antiproliferative, and Prodifferentiating Vitamin D Analog

This publication has 21 references indexed in Scilit:

• Tributyrin, a Stable and Rapidly Absorbed Prodrug of Butyric Acid, Enhances Antiproliferative Effects of Dihydroxycholecalciferol in Human Colon Cancer Cells
  Journal of Nutrition, 2001
• 1,25-Dihydroxycholecalciferol Enhances Butyrate-Induced p21Waf1/Cip1 Expression
  Biochemical and Biophysical Research Communications, 2001
• Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis
  Frontiers in Bioscience-Landmark, 2001
• New vitamin D receptor agonists with decreased metabolic stability
  Biochemical Pharmacology, 2000
• itamin D and regulation of gene expression
  Current Opinion in Clinical Nutrition and Metabolic Care, 1998
• Calcitriol and transforming growth factor‐β upregulate 5‐lipoxygenase mRNA expression by increasing gene transcription and mRNA maturation
  European Journal of Biochemistry, 1998
• EB 1089, a novel vitamin D Analog with strong antiproliferative and differentiation-inducing effects on target cells
  Biochemical Pharmacology, 1997
• Sequential induction of 5-lipoxygenase gene expression and activity in Mono Mac 6 cells by transforming growth factor beta and 1,25-dihydroxyvitamin D3.
  Proceedings of the National Academy of Sciences, 1995
• Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: Effect of cellular differentiation
  Archives of Biochemistry and Biophysics, 1991
• 1,25-Dihydroxyvitamin D₃and Human Bone-Derived Cells in Vitro: Effects on Alkaline Phosphatase, Type I Collagen and Proliferation*
  Endocrinology, 1986